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Sir,
We thank the authors for their reflections (Irving and Holden,
2013). As they acknowledge, we did not endorse the notion that
optimal care means correctly identifying and referring a patient
with cancer during the first consultation (Lyratzopoulos et al,
2013). We question whether this notion is indeed ‘widely held’. In
the United Kingdom, policy makers and cancer charities often use
a binary measure of promptness of cancer diagnosis comprising
one or two (compared with three or more) consultations, for
example, in public reporting of NHS patient experience surveys
(Department of Health, 2012). This is also the measure mainly
profiled in our paper. The main conclusions of our paper were that
the number of pre-referral consultations is a good surrogate
marker of the primary care interval; and that there is large
variation in respect of both measures between patients with
different cancers.
We would agree in principle that some repeat consultations
may be appropriate, for example, within an ‘active monitoring’
(or ‘safety-netting’) framework. The challenge for the primary
care physician is to identify the earliest point at which the
possibility of a cancer diagnosis would justify investigation or
referral. Such decisions are informed by knowledge of cancer risk
for given symptoms and by clinical practice guidelines (NICE,
2005; Hamilton, 2009). However, any decision to delay
investigation or referral as part of ‘active monitoring’ must take
into account patient preferences and the potential risk of disease
progression. Recent UK research indicates that patients express a
strong preference for investigation of symptoms likely to be due
to cancer, even when the positive predictive value of such
symptoms is known to be low (Hollinghurst et al, 2013).
Therefore, doctors need to ensure that whenever deferral of
investigation or referral is being considered, the associated
uncertainties and risks are communicated and shared with
patients. We note the authors’ work on the time efficiency
principle, but because biological processes of disease progression
vary between medical conditions, the importance of timeliness of
diagnosis and treatment may well be different in the context of
cancer (Chen et al, 2008).
The authors are correct in their assertion that cancer
presentations in primary care are relatively rare, but we would
wish to correct the illustration regarding multiple myeloma and
stomach cancer provided by the authors, who have overinterpreted
data in our paper. As we have previously alluded to, data from the
National Audit of Cancer Diagnosis in Primary Care largely reflect
the cancer ‘case-mix’ observed in population-based incidence
statistics but cannot be used to estimate incidence, not least
because data collection periods varied from 6 to 12 months
between participating practices. Using Office for National Statistics
data, the incidence per practice of multiple myeloma and stomach
cancer is in the order of 1 case every 2 years and 1 case every 18
months, respectively.
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